Long-term clinical tolerance of lovastatin and simvastatin
- PMID: 2073673
- DOI: 10.1159/000174684
Long-term clinical tolerance of lovastatin and simvastatin
Abstract
3-Hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors are gaining widespread use in the treatment of hypercholesterolemia. Clinical experience with lovastatin, which is approaching 4 years in many patients, indicates that it is well tolerated. Short-term adverse effects have usually been self-limited and have included abdominal pain, cramps, bloating, and flatus in 4-6% of cases. Raised hepatic transaminases and myopathy have occurred in 1.3 and 0.1% of cases, respectively; both, however, are reversible upon discontinuation of drug. To date, there is no evidence that lovastatin adversely affects the human lens. Overall, the drug has been well tolerated by the vast majority of patients over the long term. Early clinical experience with simvastatin shows a pattern and frequency of side effects similar to that reported with lovastatin.
Similar articles
-
Worldwide experience with simvastatin/lovastatin.Eur Heart J. 1992 Jul;13 Suppl B:21-2. doi: 10.1093/eurheartj/13.suppl_b.21. Eur Heart J. 1992. PMID: 1644097 Clinical Trial. No abstract available.
-
Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.Ann Pharmacother. 1995 Jul-Aug;29(7-8):743-59. doi: 10.1177/106002809502907-818. Ann Pharmacother. 1995. PMID: 8520093 Review.
-
Simvastatin.Aust Nurses J. 1991 Jul;21(1):29-30. Aust Nurses J. 1991. PMID: 1929970 No abstract available.
-
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.Clin Pharmacokinet. 1997 May;32(5):403-25. doi: 10.2165/00003088-199732050-00005. Clin Pharmacokinet. 1997. PMID: 9160173 Review.
-
[Simvastatin in the treatment of hypercholesterolemia].Clin Ter. 1991 Jun 15;137(5):333-7. Clin Ter. 1991. PMID: 1832606 Italian.
Cited by
-
HMG-CoA reductase inhibitor use in the aged. A review of clinical experience.Drugs Aging. 1992 Nov-Dec;2(6):518-29. doi: 10.2165/00002512-199202060-00007. Drugs Aging. 1992. PMID: 1493355 Review.
-
3 year simvastatin treatment and lens nuclear back scattering.Br J Ophthalmol. 2000 May;84(5):512-6. doi: 10.1136/bjo.84.5.512. Br J Ophthalmol. 2000. PMID: 10781516 Free PMC article. Clinical Trial.
-
Simvastatin: a pharmacoeconomic evaluation of its cost-effectiveness in hypercholesterolaemia and prevention of coronary heart disease.Pharmacoeconomics. 1992 Feb;1(2):124-45. doi: 10.2165/00019053-199201020-00009. Pharmacoeconomics. 1992. PMID: 10146941 Review.
-
Prediction of the therapeutic response to simvastatin by pretreatment lipid concentrations in 2082 subjects.Eur J Clin Pharmacol. 1994;46(2):107-14. doi: 10.1007/BF00199871. Eur J Clin Pharmacol. 1994. PMID: 8039527
-
Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.Eur J Clin Pharmacol. 1992;42(4):353-8. doi: 10.1007/BF00280117. Eur J Clin Pharmacol. 1992. PMID: 1516599
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical